Mode
Text Size
Log in / Sign up

Metachronous locally advanced rectal cancer

Part of Cancer

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Robotic ISR shows better anal function and fewer complications than laparoscopic approach
Nephrology Meta-analysis
Robotic ISR shows better anal function and fewer complications than laparoscopic approach Robotic surgery shows better anal function for low rectal cancer
A meta-analysis finds robotic intersphincteric resection improves anal function and reduces complications versus laparoscopic surgery for lo…
A review of 1,279 patients found robotic surgery for low rectal cancer led to better anal function and fewer complications than laparoscopic…
Review of sphincter-preserving techniques for ultra-low rectal cancer
Gastroenterology Sys. Review
Review of sphincter-preserving techniques for ultra-low rectal cancer New surgery keeps bowel control for ultra-low rectal cancer patients
This narrative review synthesizes evidence on six sphincter-preserving techniques for ultra-low rectal cancer. The authors report satisfacto…
A new surgical approach for ultra-low rectal cancer may better preserve bowel control and reduce the need for a permanent colostomy.
TaTME shows lower conversion rates with similar short-term safety compared to LapTME for low rectal cancer
Gastroenterology RCT
TaTME shows lower conversion rates with similar short-term safety compared to LapTME for low rectal cancer New surgical approach for rectal cancer cuts conversion rate
This randomized trial compared transanal total mesorectal excision with laparoscopic total mesorectal excision for patients with low rectal …
A new surgical technique for rectal cancer reduces the need to switch to open surgery, with similar complication rates.
Ultrasound-guided salvage brachytherapy with interstitial hyperthermia shows low toxicity in locally recurrent prostate cancer
Urology Phase II
Ultrasound-guided salvage brachytherapy with interstitial hyperthermia shows low toxicity in locally recurrent prostate cancer New prostate cancer treatment shows low side effects after 5 years
This prospective phase 2 trial evaluated ultrasound-guided salvage brachytherapy with interstitial hyperthermia in 109 patients with locally…
A new treatment for recurrent prostate cancer kept 93% of patients alive at 5 years with very low serious side effects.
S-1 plus oxaliplatin consolidation shows low toxicity in stage II/III lower rectal cancer patients
Oncology Phase I
S-1 plus oxaliplatin consolidation shows low toxicity in stage II/III lower rectal cancer patients First study reports SOX consolidation for lower rectal cancer
This Phase I study enrolled 12 patients with stage II/III lower rectal adenocarcinoma.
A small early trial found SOX chemotherapy was safe after radiation for lower rectal cancer, with surgery completed on time for all patients…
Meta-analysis shows percutaneous irreversible electroporation plus immunotherapy improves outcomes in locally advanced pancreatic cancer
Oncology Meta-analysis
Meta-analysis shows percutaneous irreversible electroporation plus immunotherapy improves outcomes in locally advanced pancreatic cancer Adding immunotherapy to ablation therapy extends life for pancreatic cancer patients
This systematic review and meta-analysis evaluated percutaneous irreversible electroporation combined with immunotherapy versus irreversible…
Adding immune therapy to ablation therapy helps patients live longer with locally advanced pancreatic cancer without causing more side effec…
Transrectal Ultrasound Characterization of Rectal Neuroendocrine Neoplasms Shows Feasibility in Small Retrospective Cohort
Orthopedics & Sports Medicine Cohort
Transrectal Ultrasound Characterization of Rectal Neuroendocrine Neoplasms Shows Feasibility in Small Retrospective Cohort Doctors use ultrasound to map rare rectal tumors before surgery
This retrospective case analysis evaluated transrectal ultrasound and contrast-enhanced ultrasound in 17 patients with rectal neuroendocrine…
A new ultrasound method helps doctors map rare rectal tumors before surgery to plan better treatment plans for patients today
Retrospective review finds higher ORR with salvage DCRT in locally advanced ESCC
Oncology Guideline
Retrospective review finds higher ORR with salvage DCRT in locally advanced ESCC Salvage therapy works better than upfront treatment for some esophageal cancer patients
This retrospective analysis of 91 patients from 3 medical centers compared salvage versus upfront definitive chemoradiotherapy (DCRT) for lo…
New data shows treating esophageal cancer after a failed first attempt may lead to better outcomes than starting with the strongest drugs im…
Systematic review finds neoadjuvant chemohormonal therapy improves biochemical progression-free survival in locally advanced prostate cancer
Oncology Meta-analysis
Systematic review finds neoadjuvant chemohormonal therapy improves biochemical progression-free survival in locally advanced prostate cancer Chemo Before Prostate Surgery Linked to Better Cancer Control
This systematic review and meta-analysis evaluated neoadjuvant chemohormonal therapy (NCHT) combined with radical prostatectomy versus radic…
Patients with advanced prostate cancer may see better cancer control with chemo before surgery, though survival gains need more proof.
Hong Kong consensus statement updates management for locally advanced and metastatic renal cell carcinoma
Oncology Guideline
Hong Kong consensus statement updates management for locally advanced and metastatic renal cell carcinoma New Kidney Cancer Rules Change How Doctors Treat Metastasis
This guideline presents a consensus statement developed by 6 urologists and 8 clinical oncologists in Hong Kong regarding locally advanced a…
New expert rules update kidney cancer care with more drug options and clearer surgery plans.
Review of case report showing durable response after surgery in metastatic bladder SqCC
Palliative Care Guideline
Review of case report showing durable response after surgery in metastatic bladder SqCC She Was Offered Hospice. Surgery Gave Her Two More Years Instead
This narrative review synthesizes a single case report of a 65-year-old woman with metastatic squamous cell carcinoma of the bladder.
A woman with a rare, drug-resistant bladder cancer that had spread to both lungs chose surgery when hospice was offered — and two years late…
Curative-intent local therapy linked to improved survival in isolated contralateral axillary breast metastasis
Oncology Cohort
Curative-intent local therapy linked to improved survival in isolated contralateral axillary breast metastasis Local therapy linked to better survival in advanced breast cancer patients with specific metastases
This retrospective cohort study of 1110 patients across two tertiary centers compared outcomes in isolated contralateral axillary metastasis…
Patients with specific breast cancer spread to the opposite armpit survived longer when receiving surgery or radiation compared to systemic …